Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,200 | -1,550 | -903 | -3,680 | -5,800 |
| Depreciation Amortization | 1 | 1 | 1 | 6 | 9 |
| Accounts payable and accrued liabilities | 262 | 216 | -6 | N/A | N/A |
| Other Working Capital | 1,221 | 820 | 248 | 2 | 170 |
| Other Operating Activity | -799 | 28 | 229 | 722 | 401 |
| Operating Cash Flow | $-515 | $-484 | $-431 | $-2,950 | $-5,220 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,471 | 933 | 446 | N/A | N/A |
| Other Financing Activity | -1,183 | -541 | 0 | 1,460 | -70 |
| Financing Cash Flow | $289 | $392 | $446 | $1,460 | $-70 |
| Exchange Rate Effect | 36 | -7 | 7 | 20 | -4 |
| Beginning Cash Position | 501 | 501 | 501 | 1,970 | 7,270 |
| End Cash Position | 311 | 402 | 524 | 500 | 1,970 |
| Net Cash Flow | $-190 | $-99 | $22 | $-1,470 | $-5,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | -515 | -484 | -431 | -2,950 | -5,220 |
| Free Cash Flow | -515 | -484 | -431 | -2,950 | -5,220 |